Navigation path

Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Teicoplanin Hospira and associated names

Product name: Teicoplanin Hospira and associated names
Also marketed in the EU under the name(s): Teicoplanin, Teicoplanin Mayne Hospira
Active substance: teicoplanin
Indication: Indicated in serious, Gram-positive infections sensitive to this antibiotic, in patients who cannot receive or who have failed to respond to penicillins and cephalosporins, or who have infections with staphylococci resistant to other antibiotics, which includes skin and soft tissue infections, urinary tract infections, lower respiratory tract infections, joint and bone infections and endocarditis.
Marketing Authorisation Holder: Hospira UK Limited

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/02/2010 Referral EMEA/H/A-29/1084 (2010)708 of 29/01/2010